Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

INTRODUCTION: Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a licensed therapy for granulomatosis with polyang...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Teixeira, Vítor, Mohammad, Aladdin J, Jones, Rachel B, Smith, Rona, Jayne, David
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Vasculitis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560673/
https://ncbi.nlm.nih.gov/pubmed/31245051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000905
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars